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Time delay after an abnormal screening mammogram may have a critical impact on tumor size, stage at diagnosis,
treatment, prognosis, and survival of subsequent breast cancer. This study was undertaken to evaluate disparities
between Latina and non-Hispanic white (NHW) women in time to definitive diagnosis of breast cancer after an
abnormal screening mammogram, as well as factors contributing to such disparities.
As part of the activities of the National Cancer Institute (NCI)-funded Redes En Acción research network, clinical
records of 186 Latinas and 74 NHWs who received abnormal screening mammogram results were reviewed to
determine the time to obtain a definitive diagnosis. Data was obtained from participating clinics in six U.S. cities
and included demographics, clinical history, and mammogram characteristics. Kaplan-Meier estimates and Cox
proportional hazards models were used to test differences in median time to definitive diagnosis by ethnicity after
adjusting for clinic site, demographics, and clinical characteristics.
Time-to-event analysis showed that Latinas took 2.2 times longer to reach 50% definitively diagnosed with breast
cancer relative to NHWs, and three times longer to reach 80% diagnosed (p=0.001). Latinas’ median time to
definitive diagnosis was 60 days compared to 27 for NHWs, a 59% gap in diagnosis rates (adjusted Hazard Ratio
[aHR] = 1.59, 95% CI = 1.09, 2.31; p=0.015). BI-RADS-4/5 women’s diagnosis rate was more than twice that of BI-
RADS-3 (aHR = 2.11, 95% CI = 1.18, 3.78; p=0.011).
Disparities in time between receipt of abnormal screening result and definitive diagnosis adversely affect Latinas
compared to NHWs, and remain significant after adjusting for demographic and clinical variables. With cancer now
the leading cause of mortality among Latinos, a greater need exists for ethnically and culturally appropriate
interventions like patient navigation to facilitate Latinas’ successful entry into, and progression through, the cancer
care system.
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Despite notable progress in the overall health of Ameri-
cans in general, disparities continue to persist in the bur-
den of illness and death experienced by Hispanics/
Latinos, as well as other ethnic groups, compared to the
U.S. population as a whole (Agency for Healthcare Re-
search and Quality 2008). With an estimated current
population of more than 45 million, Latinos are one of
the largest, youngest, and fastest-growing minority
groups in the nation, representing about 15% of the total
U.S. population (U.S. Census Bureau, American Com-
munity Survey 2006). It has been projected that by the
year 2050, Latinos will represent a quarter of the popula-
tion of the entire country (102.6 million) (U.S. Census
Bureau 2004). Cancer recently superseded heart disease
as the leading cause of morbidity and premature death
in this minority group (Siegel et al. 2012), and breast
cancer is the most frequently diagnosed cancer among
Latinas (American Cancer Society 2009).
Breast cancer mortality has been declining steadily since
1990 by an average of 2.3% per year (Howe et al. 2006).
However, while Latina women have lower breast cancer
incidence (90.2 per 100,000) than do non-Hispanic white
(NHW) or African American women (126.9 and 116.1 per
100,000, respectively), the decrease in incidence has been
smaller (0.9% compared to 1.5% per year for NHWs). The
disease continues to be the leading cause of cancer mor-
tality among Latinas, with a five-year cause-specific sur-
vival rate 5% lower than NHW women (American Cancer
Society 2009; Howe et al. 2006; American Cancer Society
2011a). Reduction in mortality is directly related to detec-
tion of early-stage breast cancer, because treatment is
more effective and treatment options and survival rates
are greater at that time (Vahabi 2003). There is strong evi-
dence from clinical trials that regular screening mammog-
raphy reduces mortality through early detection and
treatment (Elmore et al. 2005; Feig 2005; U.S. Preventive
Services Task Force 2002; Green & Taplin 2003; Knutson
& Steiner 2007). Historically, Latina women have been
less likely to utilize mammography services than NHW
women and, consequently, more likely to be diagnosed at
a more advanced stage of the disease, when fewer treat-
ment options are available (Gorin et al. 2006). In 2010,
Latina women aged 40 and older lagged behind both
NHW and African American women (46.5% compared to
51%), in reporting they had a screening mammogram in
the past year according to National Cancer Institute (NCI)
Physician Data Query guidelines (PDQ Screening and Pre-
vention Editorial Board 2012) and American Cancer Soci-
ety (ACS) guidelines (American Cancer Society 2011b).
This difference disappeared in two nationwide surveys using
updated U.S. Preventive Services Task Force (USPSTF)
recommendations of biennial screening for women aged
50–74 (U.S. Preventive Services Task Force, Screening forbreast cancer 2009): in the National Health Interview Sur-
vey (NHIS), 69.7% of Latinas and 72.8% of NHWs aged 50–
74 reported having a mammogram in the past two years
( 2012a), while the Behavioral Risk Factor Surveillance Sys-
tem (BRFSS) reported an equal proportion (75.4%) of
Latinas and NHWs aged ≥ 40 screened (Miller et al. 2012).
However, low-income Latinas and other ethnic minority
women are more likely to delay or miss follow-up appoint-
ments (Ell et al. 2007; Guerra et al. 2005; Jones et al. 2005).
These behaviors may result in poorer outcomes and higher
mortality (American Cancer Society 2009; Blackman &
Masi 2006; Newman & Martin 2007; Ramirez et al. 2000).
Many barriers contribute to Latinas’ lack of, or delay in,
follow-up when breast abnormalities are first seen (Kaplan
et al. 2005), as well as delay in treatment following diagno-
sis (Fedewa et al. 2011; Shavers & Brown 2002). Patients
face the difficult challenge of understanding and navigat-
ing the highly complex nature of, and the structural bar-
riers inherent in, the U.S. health care system, while
dealing with the emotional and physical aspects of their
health concerns and needs (Heckman et al. 2004). Barriers
include knowledge and culturally-specific health beliefs
leading to mistrust of the healthcare system and clinical
research trials; competing health, family, and work respon-
sibilities (Steinberg et al. 2006); reduced access to care;
lack of insurance and social support; cost; language issues;
lack of transportation and child care; psychological dis-
tress; poor physician-patient communication; and system
inefficiencies (Gorin et al. 2006; Ell et al. 2007). Patients
often become frustrated or discouraged and choose to dis-
continue the breast care they need. Although the majority
of women lost to follow-up after an abnormal mammo-
gram will eventually return to the system, they will most
likely present with a more advanced stage of the disease.
This study was undertaken to evaluate disparities in
time to definitive diagnosis after an abnormal screening
mammogram between Latina and NHW women in six
U.S. cities participating in the NCI-funded Redes En
Acción research network (the Six City Study) (Ramirez
et al. 2012), as well as factors contributing to such dis-
parities. We hypothesized that: 1) Latinas experience sig-
nificant delays in obtaining definitive diagnosis of breast
cancer compared with NHWs; and 2) these delays are a
result of a combination of patient- and clinic-associated
factors.
Materials and methods
Study design and procedures
Between October 2006 and December 2007, after
obtaining Institutional Review Board (IRB) approvals at
UTHSCSA and each participating study site, we
conducted a retrospective cohort study at six different
sites: San Francisco, San Diego, Miami, New York, and
Harlingen and San Antonio, Texas. Each site had high
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partnered with community clinics in those areas and
conducted an initial review of 366 medical records
of Latina and NHW women who received abnormal
screening mammograms, in order to compare the two
ethnic groups on the time to obtain a definitive diagno-
sis of breast cancer.
Inclusion criteria were Latina and NHW women
aged >30 with an abnormal screening mammogram. Mam-
mograms were defined as “abnormal” if there were suspi-
cious or incomplete results according to the American
College of Radiology (ACR) Breast Imaging and Reporting
Data Systems (BI-RADS) (Eberl et al. 2006). Categories in-
cluded were BI-RADS-0 (“indeterminate”), -3 (“probably
benign”), -4 (“suspicious”) and −5 (“highly suggestive of
malignancy”).
Medical records were reviewed to obtain age, educa-
tional attainment, language preference, dates and results
of abnormal breast cancer screening and follow-up diag-
nostic procedures (e.g. mammogram, MRI, fine-needle
aspiration, biopsy), and personal and/or family history of
breast cancer. A structured form and a companion com-
puter program were developed in Microsoft Access and
distributed to each site to enter the data. The data col-
lection was performed by a trained research staff mem-
ber, under the supervision of the investigators. This
protocol did not deviate from the local standard of care
given that it only consisted of data collection. Records
were excluded when time to definitive diagnosis (see
below) could not be estimated.
Of the 366 original charts reviewed, 30% (n=106) were
excluded due to (1) unavailability of mammogram re-
sults (n=72), or (2) BI-RADS-1 (“normal;” n=11) or −2
(“benign;” n=23) readings. Only 260 records (186 of
Latinas and 74 of NHWs) were retained for analyses
after assessment of data quality and completeness.
Study measures
The main outcome was ‘time to definitive diagnosis,’ cal-
culated as number of days from index abnormal mam-
mogram until definitive diagnosis for breast cancer was
reached. ‘Index’ referred to the most recent test perfor-
med prior to commencing the diagnostic process (Bevers
et al. 2009). Definitive diagnosis was defined as biopsy
with pathology report, or clinical determination indicat-
ing no further need for evaluation, in accordance with
protocol (Freund et al. 2008). Clinical evaluation was in-
cluded to account for variation in clinical practices. Be-
cause of the variability in the number of days to
definitive diagnosis, and the likelihood of outliers that
would result in skewed data, we censored this outcome
at a maximum of 365 days. Other studies of breast can-
cer diagnosis indicate this exceeds adequate follow-up
periods regarding clinical significance (Hershman et al.2006; National Cancer Institute 2010; Perez-Stable et al.
2012). If diagnosis did not occur within the time frame of
the study, cases remained undiagnosed and time was cal-
culated as the interval from their date of index abnormal
mammogram to the last known visit date or the end of
the study, whichever occurred first. For women with BI-
RADS-3 mammogram results and time to diagnosis >180 -
days, time to definitive diagnosis was shifted backward
180 days to account for the ACR-recommended short-
interval follow-up (repeat mammogram in six months)
(Aiello Bowles 2010; Battaglia et al. 2010). These data were
derived from patient clinical records, scheduling informa-
tion, and key informant interviews with healthcare
personnel from the clinic. Records were excluded from
analysis when time to definitive diagnosis could not be
calculated from available information, and were compared
to included records on all the independent variables for
evaluation of potentially induced bias.
The independent variable (ethnicity) was coded as ‘Latina’
and ‘Non-Hispanic white’ using a number of sources as fol-
lows: 82% of values for ethnicity were identified directly
from a medical chart-specific ethnic note. If not recorded
as such, ethnicity was imputed from self-reported national
origin, Spanish surname, or primary language given else-
where in the chart (Eschbach et al. 2005).
Covariate measures included demographic variables: age
(30–39, 40–49, 50–59, 60–69, 70+ years), insurance status
(Medicaid/Medicare only, Medicare and private, private
only, and no insurance), and language use (English only,
more English than Spanish, English and Spanish equally,
more Spanish than English, Spanish only, and other lan-
guage spoken). Education level was removed as a covariate
due to the preponderance of missing data (80% of the
sample). Multiple categories were presented to provide as
much detail as possible. Clinical characteristics serving as
covariates included personal and family history (FH) of
breast cancer (yes/no), breast density (almost entirely fat,
scattered fibroglandular densities, and heterogeneous/ex-
tremely dense), BI-RADS category, and study site (1–6).
Statistical analyses
Descriptive group characteristics were used to summarize
the data. Chi-square tests for categorical variables and Stu-
dent t-tests for continuous variables were conducted to
assess differences between groups. Median time to diag-
nosis and its corresponding 95% confidence interval (CI)
was used to describe duration of the diagnostic period.
Kaplan-Meier estimates for the proportion of undiagnosed
women at different times were calculated across each level
of the independent variables, and compared using the log-
rank test. Time to diagnosis between Latinas and NHWs
was then compared using Cox proportional hazards models
to obtain adjusted estimates of hazard ratios (aHRs), con-
trolling for significant covariates. Shared-frailty models were
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Janssen 2008; Therneau & Grambsch 2000). Hazard ra-
tios >1.0 are consistent with a shorter time to diagnosis. All
analyses were conducted using Stata Version 12.1 (2012,
StataCorp LP, College Station, TX).Table 1 Sample demographics and clinical characteristics
Latina Women (n=186 ) Non
n %
Age
30 – 39 9 4.8
40 – 49 57 30.7
50 – 59 64 34.4
60 – 69 42 22.6
70+ 9 4.8
N/A 5 2.7
Age in years (mean, SD) 53.5 9.5
Insurance
Medicaid/Medicare 36 19.4
Medicare + private 7 3.8
Private only 31 16.7








Almost entirely fat 8 4.3
Scattered fibroglandular densities 42 22.6
Heterogeneous/extremely dense 62 33.3
N/A 74 39.8
BI-RADS
BI-RADS 0 35 18.8
BI-RADS 3 35 18.8








Note: SD = standard deviation; N/A = not documented in medical record; HS = Hig
Systems; * = no patient records reported.Results
To identify factors influencing time to definitive diagno-
sis, we reviewed clinic records of Latinas and NHWs
with abnormal screening mammograms from six U.S.
cities participating in the NCI-funded Redes En Acción-Hispanic White Women (n=74 ) Total (n=260 )
n % n % χ2 / t p
11.79 0.019
2 2.7 11 4.2
17 23.0 74 28.5
24 32.4 88 33.9
17 23.0 59 22.7
13 17.6 22 8.5
1 1.4 6 2.3
58.1 10.9 54.8 10.1 −3.38 <0.001
40.94 <0.001
6 8.1 42 16.2
20 27.0 27 10.4
21 28.4 52 20.0
27 36.5 139 53.5
1.87 0.17
8 10.8 19 7.3
66 89.2 241 92.7
14.52 <0.001
21 28.4 39 15.0
53 71.6 221 85.0
3.90 0.14
4 5.4 12 4.6
20 27.0 62 23.9
14 18.9 76 29.2
36 48.7 110 42.3
2.18 0.33
9 12.2 44 16.9
18 24.3 53 20.4
47 63.5 163 62.7
49.07 <0.001
25 33.8 45 17.3
* * 34 13.1
9 12.2 28 10.8
29 39.2 73 28.1
11 14.9 44 16.9
* * 36 13.9
h School; BC = breast cancer; BI-RADS = Breast Imaging and Reporting Data
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to the study (data not shown). Clinic size ranged from
small practices (5–30 physicians) in suburban or small-
to-medium-sized metropolitan areas, to hospitals and
medical centers in urban areas (100-500+ bed capacity
and 150–1500 physicians). Approximately half the clinics
were public non-federal government facilities, and the
rest were private non-profits. The percentage of iden-
tified Latinas attending these facilities ranged from 10% in
Brooklyn, 25% in the Bay Area, 45% in Miami, to >90% at
the San Diego and Texas sites.
Table 1 shows sample demographics and clinical charac-
teristics. Data was collected from a total of 260 women,
72% (n=186) of whom were Latina. Mean age was 53.5 -
years (SD=9.5) for Latinas, significantly younger than
NHWs (mean 58.1, SD=10.9, p<0.001). Most Latina
women had no health insurance (60% vs. 37% of NHWs,
p <0.001). Among Latinas, significantly more women
(33%) spoke predominantly or only Spanish compared to
English (16%; χ2=51.07, p<0.001; data not shown). The
majority of both groups had no personal history (94% and
89% of Latinas and NHWs, respectively), or FH (90% and
72% of Latinas and NHWs, respectively), of breast cancer.
Mammography results revealed no significant differences
in breast density (χ2=3.90, p=0.14) or BI-RADS category






186 90(58) 48(18) 31(11) (3)Latinas
74 31(34) 17(11) 11(6) (1)NHWs
 
0 30 60 90
Time to definitiv
No. of abnormalities (No. of resolved)
Figure 1 Kaplan-Meier estimates of the cumulative proportion of wom
biopsy with pathology report, or clinical determination indicating no furthe
mammogram abnormalities were resolved.Figure 1 shows the Kaplan-Meier estimates of the cu-
mulative proportion of diagnosed women by group at
different times. Time for 50% of Latinas to reach a de-
finitive diagnosis was 60 days (SE=8.14; 95% CI 45, 74),
significantly longer than NHWs (27 days; SE=5.26; 95%
CI 19, 53) (see also Table 2). This gap increased when
time for 80% of women to reach diagnosis was calcu-
lated, where it took 226 days for Latinas and 71 days for
NHWs (χ2=10.32, p=0.001).
Table 2 shows median time to definitive diagnosis in days
by ethnicity, sample demographics, and clinical characteris-
tics. Ethnicity (χ2=10.32, p=0.001), insurance (χ2=8.06,
p=0.04), and BI-RADS category (χ2=18.31, p<0.001) were
associated with time to definitive diagnosis in the log-
rank test. There was no association based on age category,
personal or FH of breast cancer, or abnormal breast density
on mammography.
Table 3 shows adjusted hazard ratios (aHR) for Cox pro-
portional hazards models of median time to definitive
diagnosis. Only covariates that were significantly different
by log-rank test (Table 2) were included in the models.
When adjusted by site only, ethnicity and more severe
BI-RADS category were significantly associated with time
to definitive diagnosis. NHWs had a 49% higher rate of
definitive diagnosis of breast cancer than Latinas (95% CI
1.03, 2.13; p=0.035), and women with BI-RADS-4/5 mam-
mograms likewise were diagnosed at a higher rate thanP = 0.001
22 20(2) 19(0) 14(4) 11(3)
10 8(1) 6(1) 2(2) 0(2)




en diagnosed by group. Note: Definitive diagnosis was defined as
r need for evaluation. Figure is truncated at 240 days, when all NHW
Table 2 Median time to definitive diagnosis (days since index abnormal mammogram) – By ethnicity, demographics,
and clinical characteristics
Latina Women (n=186) Non-Hispanic White Women (n=74) Total (n=260) Log-rank test
Median 95% CI Median 95% CI Median 95% CI χ2 p
Ethnicity 60 45 74 27 19 53 50 38 60 10.32 0.001
Age (years) 7.53 0.11
30 – 39 33 3 - 12 12 - 20 7 51
40 – 49 61 35 218 32 3 125 51 32 82
50 – 59 70 35 149 22 9 50 50 29 71
60 – 69 60 35 197 58 19 100 60 38 95
70+ 27 7 - 27 7 62 27 16 53
N/A - 17 - - - - 195 17 -
Insurance 8.06 0.04
Medicaid/Medicare 51 24 199 23 9 - 46 24 197
Medicare + private 218 72 - 60 27 - 64 53 218
Private only 198 39 260 33 12 58 66 35 198
No insurance 48 27 70 20 8 32 42 20 56
History of BC 0.08 0.78
Yes 13 5 198 19 3 - 19 11 197
No 60 45 74 32 20 53 50 39 60
Family History of BC 0.30 0.58
Yes 46 29 260 26 12 62 46 16 64
No 61 43 74 32 19 56 51 38 65
Breast density 2.73 0.25
Almost entirely fat 13 5 - 23 7 - 18 7 35
Scattered fibroglandular densities 51 24 86 19 2 32 35 16 56
Heterogeneous/extremely dense 50 18 199 22 9 - 42 18 61
N/A 149 66 198 58 23 66 66 56 149
BI-RADS Category 18.31 <0.001
BI-RADS-0 98 70 - 60 4 - 82 60 107
BI-RADS-3 95 74 - 66 19 - 125 66 -
BI-RADS-4/5 38 20 50 26 16 50 33 22 46
Note: N/A = not documented in medical record; HS = High School; BC = breast cancer; - = not enough data to estimate confidence interval; BI-RADS = Breast Imaging
and Reporting Data Systems.
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After adjusting for both site and BI-RADS, the rate of
diagnosis for NHWs remained significantly higher than
for Latinas (aHR=1.59; 95% CI 1.09, 2.31; p=0.015). BI-
RADS-4/5 also led to a higher rate of definitive diagnosis
in the multivariate model (aHR = 2.11; 95% CI 1.18, 3.78;
p=0.011). Insurance status did not influence time to de-
finitive diagnosis.
Discussion
Our study results indicate that Latina ethnicity plays a sig-
nificant role in delaying median time to diagnosis of breast
cancer in a multi-site sample. This supersedes age, educa-
tion, insurance status, personal or family history of breastcancer, and mammographic breast density abnormalities.
In contrast, results from the CDC’s National Breast and
Cervical Cancer Early Detection Program (NBCCEDP)
(Caplan et al. 2000) showed diagnosis occurring in <60 -
days for a majority of women regardless of ethnicity. One
possible reason for this difference is that none of our clinic
sites participated in the CDC program. Another explan-
ation could be the relatively late arrival of Latina-focused
breast cancer research. Most disparity studies in the past
six years have compared white and African American pop-
ulations (Gorin et al. 2006; Blackman & Masi 2006; New-
man & Martin 2007), and the ACS’s latest Facts and
Figures publication likewise focused on these two groups
(American Cancer Society 2011c). In a recent study by
Table 3 Factors associated with time to definitive diagnosis of breast cancer
Site-adjusted hazard ratios Multivariate-adjusted model*
aHR 95% CI p aHR 95% CI p
Ethnicity
Latina 1.00 Ref. 1.00 Ref.
Non-Hispanic White 1.49 1.03 2.13 0.035 1.59 1.09 2.31 0.015
Insurance
Medicaid/Medicare 1.04 0.65 1.65 0.873
Medicare + private 0.98 0.47 2.06 0.961
Private only 0.92 0.56 1.51 0.737
No insurance 1.00 Ref.
BI-RADS
BI-RADS 0 1.60 0.74 3.45 0.231 1.80 0.83 3.90 0.137
BI-RADS 3 1.00 Ref. 1.00 Ref.
BI-RADS 4/5 1.95 1.10 3.49 0.023 2.11 1.18 3.78 0.011
Note: aHR = adjusted Hazard Ratio; Ref. = reference category; BI-RADS = Breast Imaging and Reporting Data Systems. * = adjusted for site and BI-RADS category.
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of women surveyed, 84% of BI-RADS-4/5 women were di-
agnosed by the recommended 60-day limit. Women with
BI-RADS-3 results took significantly longer (183 days vs.
29 for BI-RADS-4/5) to reach diagnosis or resolution as
defined by the authors (Perez-Stable et al. 2012). This is
consistent with our own findings in this study and else-
where (Ramirez et al. 2012).
Time-to-event analyses have been done to examine
breast cancer recurrence mediated by cancer subtype
(Buist et al. 2010), effects of patient navigation (PN) on
time to diagnostic resolution in breast and cervical cancer
(Markossian et al. 2012), and surgical risk reduction in
women with familial ovarian cancer (Manchanda et al.
2012). To our knowledge, this is the first study using
time-to-event analysis to examine the disparity in time to
definitive diagnosis of breast cancer between Latinas and
NHWs. Our data showed an increasing time lag for
Latinas relative to NHWs, from twice as long for 50% of
Latinas to be diagnosed, to three times to achieve 80%
diagnosed.
Limitations of our study include its retrospective de-
sign and dependence on medical records, resulting in
the unavailability (N/A) of specific data (e.g., educational
attainment – see Table 1) across study sites. Thus, site-
by-site comparisons could not be made; instead, a
pooled analysis was done to interpret available data. This
also contributed to the imbalance in total number of eli-
gible Latina and NHW records examined across sites
(χ2=49.07, p<0.001), which likely accounts for the signifi-
cant differences observed in 50% of group characteris-
tics. Moreover, our conclusions are limited to Latinas
and NHWs, to the exclusion of other minority popula-
tions (e.g., African-Americans), in whom the substantial
challenge to decrease breast cancer incidence, morbidityand mortality remains (Blackman & Masi 2006; Fedewa
et al. 2011; 2012b).
Studies have repeatedly shown that cancer places an un-
equal burden among women who are of lower socioeco-
nomic status and/or ethnic minorities (Jones et al. 2005;
Caplan et al. 2000; Chang et al. 1996; Kerlikowske 1996).
These disparities manifest themselves in lower survival
rates and have been shown to result from a cluster of cir-
cumstances, including minority status and marginalization,
inability to access and adequately utilize medical resources,
unavailability of those resources in some locales, late diag-
noses and more severe disease, and similar delays in treat-
ment ultimately leading to higher rates of death (Eberl et al.
2006; Peres 2010; Karliner & Kerlikowske 2007). Our study
highlights the significance of ethnicity in delaying breast
cancer diagnosis among Latinas, who represent a minority
group considered the youngest and fastest-growing in the
U.S. (U.S. Census Bureau, American Community Survey
2006). Our results underscore the clear need for increased
Latina-targeted breast cancer prevention and screening
services as part of a multi-level approach to cancer care de-
livery (Taplin et al. 2012) that ultimately improves quality
of care by improving outcomes.
One of the Healthy People 2020 objectives is to in-
crease breast cancer screening by 10% from the current
73.7% of females who receive guideline-based scree-
ning (Centers for Disease Control and Prevention and
National Center for Health Statistics 2012a). However,
for Latinas the current age-adjusted rate is only 68.3%
(Centers for Disease Control and Prevention and Na-
tional Center for Health Statistics 2012b), thus necessi-
tating even greater efforts to reach this goal. Moreover,
with cancer now the leading cause of death among
Latinos (Siegel et al. 2012), research and intervention ef-
forts need to expand to decrease lag time between index
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gested interventions to ameliorate disparities have in-
cluded counseling, health education, and PN (Blackman
& Masi 2006). Such interventions, applied correctly and
in a timely fashion to specific target populations (Ramirez
et al. 2012) and clinical challenges (Freeman 2012; Fiscella
et al. 2012; Battaglia et al. 2012; Paskett et al. 2012) should
streamline the continuum of cancer care from screening
through survivorship.
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